BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Earnings
Cellectar Biosciences  (NVLT) Reports Second Quarter 2014 Financial Results And Recent Highlights 8/21/2014
Ablynx (ABLYF) Will Announce Its Half-Year Results For 2014 With Webcast 8/21/2014
China Cord Blood Corporation To Report First Quarter Of Fiscal 2015 Financial Results 8/21/2014
Medivir AB (MVRBF): Interim Report, January – June 2014* 8/21/2014
DiaGenic ASA: Q2 2014 - Financial Report 8/21/2014
Karolinska Development AB (publ) – Interim Report January – June 2014 8/21/2014
MDxHealth, Inc. (MXDHF) Reports First Half Year 2014 Results 8/21/2014
Skyepharma PLC (SKYEF) Interim Results Statement 8/21/2014
TiGenix: Convening Notice To The Extraordinary Shareholders' Meeting To Be Held On 8 September 2014 8/21/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Third Quarter Fiscal Year 2014 8/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Jun. 2014 8/20/2014
Hikma Pharmaceuticals Delivers Excellent First Half Results With 16% Revenue Growth And 44% Increase In Adjusted EPS 8/20/2014
Source BioScience Release: Half Year Report For The Six Months Ended 30 June 2014 8/20/2014
Cellectar Biosciences  (NVLT) To Host Conference Call On August 20th To Discuss Second Quarter 2014 Results And Provide Quarterly Update On Development Progress 8/19/2014
PDL BioPharma, Inc. (PDLI) Announces Second Quarter 2014 And Year To Date Financial Results 8/19/2014
Probi: Highest-Ever Net Sales For A Single Quarter 8/19/2014
Notice Of Zealand Pharma  (ZEAL.CO)'s Interim Report For H1 2014 And Related Conference Call 8/18/2014
Bio-Path Holdings, Inc. (BPTH) Reports Second Quarter 2014 Operational and Financial Results 8/18/2014
PDL BioPharma, Inc. (PDLI) Announces Plans To Issue Second Quarter Financial Results After Market Today And Reschedules Earnings Call For Tuesday, August 19 At 4:30pm EDT 8/18/2014
GlobeImmune, Inc. (GBIM) Announces Second Quarter 2014 Financial Results 8/18/2014
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Third Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 8/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2015 8/15/2014
ZS Pharma (ZSPH) Announces Second Quarter 2014 Financial Results 8/15/2014
Aurinia (ISA.TO) Reports Second Quarter 2014 Financial Results 8/15/2014
Arno Therapeutics Reports Second Quarter 2014 Financial And Business Update 8/15/2014
Kite Pharma, Inc. Reports Second Quarter 2014 Results 8/15/2014
Opexa Therapeutics (OPXA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/15/2014
RestorGenex Reports Second Quarter 2014 Financial Results 8/15/2014
Agilent Technologies Inc. (A) Reports Third-Quarter 2014 Results 8/15/2014
La Jolla Pharmaceutical Company (LJPC) Announces Second Quarter And Year-To-Date 2014 Financial Results 8/15/2014
Targeted Medical Pharma Reports Second Quarter 2014 Financial Results 8/15/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter Financial Results 8/15/2014
Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results 8/15/2014
Ruthigen Reports Fiscal First Quarter 2015 Financial Results 8/15/2014
Intrexon Corporation Announces Second Quarter And First Half 2014 Financial Results 8/15/2014
Dyadic International, Inc. Reports Q2 2014 Financial Results 8/15/2014
Nephros Inc. (NEP) Reports Second Quarter 2014 Financial Results 8/15/2014
Echo Therapeutics (ECTE) Announces Second Quarter 2014 Financial Results and Provides Business Update 8/14/2014
Heat Biologics Reports 2014 Second Quarter Financial Results 8/14/2014
Stemline Therapeutics, Inc. (STML) Provides Second Quarter 2014 Financial Results And Corporate Update 8/14/2014
Aastrom Biosciences, Inc. (ASTM) Reports Second Quarter 2014 Financial Results 8/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For Quarter Ended June 30, 2014 8/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Second Quarter 2014 Financial Results 8/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Second Quarter 2014 Financial Results 8/14/2014
Cellular Biomedicine Group (CBMG) Reports Second Quarter And First Half 2014 Financial Results And Provides Business Highlights 8/14/2014
Perrigo Company (PRGO) Announces Quarterly Dividend 8/14/2014
Interleukin Genetics Inc. (ILGN) Reports Second Quarter 2014 Financial Results 8/14/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/14/2014
SAGE Therapeutics Reports Second Quarter 2014 Financial Results 8/14/2014
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014
22nd Century Group, Inc. Reports Second Quarter 2014 Financial Results 8/14/2014
Veracyte, Inc. (VCYT) Announces Second Quarter 2014 Financial Results 8/14/2014
Rexahn Pharmaceuticals, Inc. (RNN) Reports Second Quarter 2014 Financial Results And Pipeline Update 8/14/2014
BASi (BASI) Reports Third Quarter Net Income Of $.03 Per Share 8/14/2014
PDI, Inc. (PDII) Reports 2014 Second Quarter Financial Results 8/14/2014
WuXi PharmaTech Co., Ltd. Announces Second-Quarter 2014 Results 8/14/2014
Imprimis Pharmaceuticals (immy) Announces Second Quarter 2014 Financial Results And Provides Operational Update 8/14/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January – June 2014 8/14/2014
Recipharm AB: Interim Report January-June 2014 8/14/2014
InSite Vision (ISV) Reports Second Quarter 2014 Financial Results 8/14/2014
Concordia Healthcare Corp (CXR.TO) Announces Financial And Operational Results For Its Second Quarter, Ended June 30, 2014 8/14/2014
DATATRAK International, Inc. (DATA) Reports Second Quarter Results Of 2014 8/14/2014
Concord Medical Services Holdings Limited (CCM) Reports Second Quarter 2014 Financial Results 8/14/2014
Synthetic Biologics, Inc. (SYN) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/14/2014
CASI Pharmaceuticals  (ENMD) Reports Second Quarter 2014 Financial Results 8/14/2014
RXi Pharmaceuticals (RXII) Reports Financial Results For The Second Quarter Of 2014 8/14/2014
Perrigo Company (PRGO) Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins 8/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Second Quarter 2014 Financial Results 8/14/2014
VWR International, Inc. To Hold Second Quarter 2014 Financial Results Conference Call 8/14/2014
Cord Blood America, Inc. Announces 2014 Second Quarter Financial Results 8/14/2014
RBC Life Sciences, Inc. Reports Second Quarter Results 8/14/2014
HEALTHSOUTH To Present At The Baird 2014 Healthcare Conference 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Inergetics, Inc.: 2014 Second Quarter Earnings Announcement 8/14/2014
Microbix Biosystems Inc. (MBXBF)’ Virology Revenue Grows 24% In Third Quarter, Company Reports Fourth Consecutive Quarterly Profit 8/14/2014
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On August 18, 2014 8/13/2014
Anavex Life Sciences Corp. (AVXL.OB) Reports Fiscal Third Quarter 2014 Financial Results 8/13/2014
SCYNEXIS, Inc. (SCYX) Reports Second Quarter 2014 Financial Results 8/13/2014
Epizyme (EPZM) Announces Second Quarter 2014 Financial Results And Provides Corporate Update 8/13/2014
Eleven Biotherapeutics (EBIO) Reports Second Quarter 2014 Financial Results 8/13/2014
TetraPhase Pharmaceuticals Reports Second-Quarter 2014 Financial Results 8/13/2014
bluebird bio (BLUE) Reports Fiscal Second Quarter 2014 Financial Results 8/13/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Third Quarter Financial Results And Provides Update On ARC-520 8/13/2014
Ignyta (RXDX) Announces Second Quarter 2014 Company Highlights And Financial Results 8/13/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014 8/13/2014
Ambit Biosciences Announces Second Quarter 2014 Operating Results 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Capricor Therapeutics, Inc. Reports Second Quarter 2014 Financial & Business Highlights 8/13/2014
Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial Results 8/13/2014
Emisphere Technologies, Inc. (EMIS) Announces Second Quarter 2014 Earnings Conference Call 8/13/2014
Kindred Bio (KIN) Announces Second Quarter 2014 Financial Results 8/13/2014
Lipocine Inc. (LPCN) Announces Financial And Operational Results For The Second Quarter Of 2014 8/13/2014
Conatus Pharmaceuticals Inc. Reports Second Quarter 2014 Financial Results And Program Updates 8/13/2014
Onconova Therapeutics Inc. (ONTX) Reports Second Quarter 2014 Financial And Operational Results 8/13/2014
Evoke Pharma, Inc. Reports Second Quarter 2014 Results 8/13/2014
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014
Zafgen (ZFGN) Reports Second Quarter 2014 Financial Results 8/13/2014
Tekmira Pharmaceuticals Corporation (TKMR) Provides Corporate Update And Announces Second Quarter 2014 Results 8/13/2014
Epigenomics AG Announces H1 2014 And Q2 2014 Financial Results And Reports On Operational Highlights 8/12/2014
Dipexium Pharmaceuticals (DPRX) Reports Second Quarter 2014 Financial and Operational Results 8/12/2014
CytoSorbents, Inc. Records Another Solid Quarter Of Growth In Q2 2014 8/12/2014
Fate Therapeutics (FATE) Reports Second Quarter 2014 Financial Results 8/12/2014
StemCells Inc. (STEM) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $49.0 Million For The Second Quarter Ended June 30, 2014 8/12/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Second Quarter 2014 Financial Results 8/12/2014
ReVance Therapeutics, Inc. (RVNC) Releases Second Quarter 2014 Financial Results 8/12/2014
Cerulean Pharma Inc. (CERU) Reports Second Quarter 2014 Corporate Highlights And Financial Results 8/12/2014
Corium International, Inc. Reports Third Fiscal Quarter 2014 Financial Results 8/12/2014
Ocera Therapeutics, Inc. (OCRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Relypsa, Inc. (RLYP) Announces Second Quarter 2014 Financial Results 8/12/2014
Intercept Pharmaceuticals (ICPT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Achaogen (AKAO) Announces Second Quarter 2014 Results 8/12/2014
Aquinox Pharmaceuticals (AQXP) Announces Second Quarter 2014 Financial Results 8/12/2014
Galena Biopharma  (GALE) Reports Second Quarter 2014 Results 8/12/2014
Supernus Pharmaceuticals (SUPN) Announces Second Quarter 2014 Results 8/12/2014
Cellular Dynamics International International Reports Second Quarter 2014 Financial Results 8/12/2014
Athersys, Inc. (ATHX) Reports Second Quarter 2014 Results 8/12/2014
Apricus Biosciences (APRI) Provides Corporate Update And Second Quarter 2014 Financial Results 8/12/2014
Evotec AG (EVTG.F) Reports Results Of First Half Of 2014 8/12/2014
Recro Pharma (REPH) Reports Second Quarter 2014 Financial Results 8/12/2014
Akers Biosciences, Inc. Reports Its Second Quarter Financial Results 8/12/2014
ProSensa Holding N.V. (RNA) Announces 2nd Quarter 2014 Financial Results And Recent Corporate Developments 8/12/2014
Intra-Cellular Therapies, Inc. Reports Financial Results For Second Quarter Ended June 30, 2014 8/12/2014
Receptos (RCPT) Reports Second Quarter 2014 Financial Results 8/12/2014
Radius (RDUS) Reports Second Quarter 2014 Financial And Operating Results 8/12/2014
Aurinia (ISA.TO) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/12/2014
Synergy Pharmaceuticals Reports Second Quarter And First Half 2014 Financial Results 8/12/2014
Opko Health, Inc. Announces Second Quarter Operating And Financial Results 8/12/2014
AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2014 Financial Results 8/12/2014
ADMA Biologics, Inc. Reports Second Quarter 2014 Financial And Operational Results 8/12/2014
NephroGenex (NRX) Reports Second Quarter 2014 Financial Results 8/12/2014
BioSpecifics Technologies Corporation (BSTC) Reports Second Quarter 2014 Financial Results 8/12/2014
AVEO Oncology (AVEO) Reports Second Quarter 2014 Financial Results And Updates Progress On Strategic Plan 8/12/2014
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014
Cytori Therapeutics, Inc. (CYTX) Reports Second Quarter 2014 Business And Financial Results 8/12/2014
Oncothyreon Inc. (ONTY) Reports Second Quarter 2014 Financial Results 8/12/2014
Acceleron Pharma Reports Second Quarter 2014 Financial Results 8/12/2014
Retrophin, Inc. (RTRX) Reports Second Quarter 2014 Financial Results 8/12/2014
Halozyme Therapeutics, Inc. (HALO) Reports Second Quarter 2014 Financial Results 8/12/2014
Taxus Cardium (CRXM) Presents Second Quarter 2014 Financial Results And Recent Developments 8/12/2014
Rock Creek Pharmaceuticals Reports Second Quarter And Announces Clinical Update 8/12/2014
BioTime (BTX) Announces Second Quarter 2014 Results And Recent Developments 8/12/2014
Idera Pharmaceuticals, Inc. (IDRA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/12/2014
Concert Pharmaceuticals, Inc. (CNCE) Reports Second Quarter 2014 Financial Results And Provides Company Update 8/12/2014
Trevena, Inc. (TRVN) Reports Second Quarter 2014 Financial Results 8/12/2014
Regado Biosciences, Inc. (RGDO) Announces Second Quarter 2014 Financial Results And Corporate Highlights 8/12/2014
Egalet Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014
Aratana Therapeutics (PETX) Reports Second Quarter 2014 Results 8/12/2014
Array BioPharma, Inc. (ARRY) Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 8/12/2014
GenVec Inc. (GNVC) Reports Second Quarter 2014 Financial Results 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
ChromaDex, Inc. Reports Second Quarter Ingredient Sales Grew 155% Year-Over-Year And 52% Sequentially 8/12/2014
Intrexon Corporation To Announce First Half And Second Quarter 2014 Results And Host Conference Call On August 14th 8/12/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Reports Financial Results For The Three And Six Months Ended June 30, 2014 8/12/2014
Delcath Systems, Inc. (DCTH) Losses Reach $11.4 Million For The First Half Of 2014 8/11/2014
Akers Biosciences, Inc. Announces Conference Call To Discuss Its Second Quarter And Six Months Financial Results 8/11/2014
Geron Corporation (GERN) Reports Second Quarter 2014 Financial Results 8/11/2014
Rock Creek Pharmaceuticals Reports Second Quarter And Announces Clinical Update 8/11/2014
Merrimack Pharmaceuticals Inc. (MACK) Reports Second Quarter 2014 Financial Results 8/11/2014
Repligen Corporation (RGEN) Reports Second Quarter 2014 Financial Results 8/11/2014
Alcobra (ADHD) Announces Second Quarter Financial Results And Provides Corporate Update 8/11/2014
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2014 8/11/2014
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2014 Financial Results 8/11/2014
MannKind Corporation (MNKD) Reports 2014 Second Quarter Financial Results 8/11/2014
Ultragenyx Pharmaceuticals (RARE) Reports Second Quarter 2014 Financial Results And Corporate Update 8/11/2014
Repros Therapeutics Inc. (RPRX) Reports Second Quarter 2014 Financial Results 8/11/2014
Nymox Pharmaceutical (NYMX) Reports Second Quarter 2014 Financial Results 8/11/2014
Aastrom Biosciences, Inc. (ASTM) To Host Second Quarter 2014 Earnings Call On August 14, 2014 8/11/2014
Coronado Biosciences (CNDO) Reports Financial Results 8/11/2014
PDI, Inc. (PDII) To Hold Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/11/2014
Akebia Therapeutics, Inc. (AKBA) Announces Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Releases Fourth Quarter And Full Year 2014 Results 8/11/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Third Quarter Ended June 30, 2014 8/11/2014
Eagle Pharmaceuticals (EGRX) Reports Third Quarter 2014 Results 8/11/2014
Fibrocell Science, Inc. Reports Second Quarter And First Half 2014 Financial And Operating Results 8/11/2014
Opexa Pharmaceuticals, Inc. Announces News Release And Conference Call Schedule To Discuss Second Quarter 2014 Financial Results 8/11/2014
Cardiome Pharma Corp. (COM.TO) Reports Second Quarter 2014 Financial Results 8/11/2014
Soligenix (SNGX) Reports Second Quarter 2014 Financial Results, And Highlights Recent Accomplishments 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
CEL-SCI (CVM) Reports Third Quarter Fiscal 2014 Financial Results 8/11/2014
Invitation To Presentation Of Recipharm AB’s Interim Report For The Second Quarter Of 2014 On August 14th 8/11/2014
Pernix Therapeutics, Inc. (PTX) Reports Second Quarter 2014 Financial Results 8/11/2014
Chindex International, Inc. (CHDX) Reports Financial Results For Second Quarter And First Half Of 2014 8/11/2014
Inovio Pharmaceuticals (INO) Reports 2014 Second Quarter Financial Results 8/11/2014
Telik, Inc. (TELK) Announces New Board Of Director Members To Oversee Reinvigorated Cancer Therapy Pipeline Resulting From The Recent Merger With MabVax Therapeutics, Inc. 8/11/2014
WaferGen Biosystems Reports Strong Revenue Growth For Q2 2014 8/8/2014
Bioheart, Inc. Releases Q2 Financial Information Showing Growth 8/8/2014
Amicus Therapeutics, Inc. (FOLD) Announces Second Quarter 2014 Financial Results And Corporate Updates 8/8/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Second Quarter 2014 Financial Results 8/8/2014
Receptos (RCPT) To Hold Second Quarter 2014 Financial Results Conference Call And Webcast 8/8/2014
Auspex Pharmaceuticals Reports Second Quarter 2014 Results 8/8/2014
Cara Therapeutics, Inc. (CARA) Reports Second Quarter 2014 Financial Results 8/8/2014
Minerva Neurosciences, Inc. (NERV) Reports Second Quarter 2014 Financial Results 8/8/2014
Aratana Therapeutics (PETX) To Report Second Quarter Financial Results 8/8/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Reports Financial Results For Second Quarter 2014 8/8/2014
XOMA (US) LLC (XOMA) Highlights Recent Achievements And Reports Financial Results For Second Quarter 2014 8/8/2014
Progenics Pharmaceuticals, Inc. (PGNX) Announces Second Quarter 2014 Financial Results 8/8/2014
BioLife Solutions, Inc. (BLFS.OB) Announces Second Quarter 2014 Results 8/8/2014